6
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Patent Evaluation: Pyridinium compounds as PAF agonists

Pages 1523-1524 | Published online: 03 Mar 2008
 

Abstract

Novelty: Aryl, amide, imide and carbamate derivatives of pyridine are disclosed as antagonists of PAF. They may be used to treat asthma, endotoxic shock, transplant rejection, thrombosis, stroke and cancer.

Biology: In vitro PAF antagonism was assayed using blood from NZ rabbits and inhibition of aggregation was 0-97%. In vivo survival after PAF-induced lethality in mice was increased by 0-69% in two hours and survival out of fifteen from acute endotoxaemia was increased to 0-14 (control, endotoxin only = 0-6).

Chemistry: One hundred and forty-eight examples of syntheses of the compounds by standard techniques are provided. Characterization is by mp, ms and elemental analysis. A preferred compound is 2-[[acetyl[4-(tetradecyloxy)benzoyl]amino]methyl]-1-methylpyridinium iodide.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.